Xcout Intel
AI Proteins, Inc.
AI Proteins, Inc. is a growing biotechnology company based in Boston, Massachusetts, that aims to transform the development of oral biologic therapies for major diseases.
Subscribe to see AI Proteins, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
AI Proteins, Inc. at a glance
AI Proteins, Inc. is a protein therapeutics company headquartered in United States. It has raised at least $84.3M across the 5 funding rounds on record. Its most recent funding round raised $5M in March 2024. Xcout tracks 4 named people at AI Proteins, Inc., including James Bowman, PhD (Chief Technology Officer).
AI Proteins, Inc. leadership
- James Bowman, PhDChief Technology Officer
- Philip E. Brandish, PhDChief Scientific Officer
- Wendy DwyerChief Business Officer
- Chris BahlPresident, Chief Executive Officer, Founder
AI Proteins, Inc. funding rounds
At least $84.3M raised across the 5 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $5M | — | |
| SEC Form D filing | $8.3M | — | |
| — | $18.2M | 4 named | |
| SEC Form D filing | $11.3M | — | |
| Series A | $41.5M | 4 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
AI Proteins, Inc. competitors
A few of AI Proteins, Inc.'s closest competitors — see the full list of competitors and alternatives →
Expedition Medicines, Inc. is a biotechnology company founded in 2022 and headquartered in Cambridge, Massachusetts, focused on generatively designing novel drugs targeting specific proteins.
Aikium is a biotechnology company headquartered in Berkeley, California, that integrates deep learning with ultra-large-scale wet lab experimentation to advance protein therapeutics.
DeepCure is a Boston-based therapeutics company that harnesses advanced AI, physics-based tools, and automation to discover novel small molecules.
Protai Bio is an Israeli biotechnology company leveraging artificial intelligence and proteomics to advance drug discovery pipelines.
GRO Biosciences Inc. is an emerging biotechnology company headquartered in Cambridge, Massachusetts. The company leverages groundbreaking science to expand the amino acid alphabet and deliver on the promise of advanced protein therapeutics.
Bonito Biosciences is a life-science company headquartered in Waltham, Massachusetts, building a delivery ligand discovery platform that combines encoded libraries, functional live-cell selections, and AI.
Get AI Proteins, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on AI Proteins, Inc. in Xcout Intel
- 4 named people with titles, LinkedIn and board committees
- 5 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access